Evidence map›Paper›PMID 37855322›Full record

ArticleEndocrine-related cancer2023

Mammary gland development and EDC-driven cancer susceptibility in mesenchymal ERα-knockout mice.

Clarissa Wormsbaecher, Brittney M Cumbia, Emma G Amurgis, Jillian M Poska, Madeline R Price, Xiaokui M Mo, Sue E Knoblaugh, Takeshi Kurita, Craig Joseph Burd

Open access · greenAbstract read
In one paragraph

Article in Endocrine-related cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Clarissa WormsbaecherDepartment of Molecular Genetics, The Ohio State University, Columbus, Ohio, USA.
Brittney M CumbiaThe Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Emma G AmurgisThe Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Jillian M PoskaDepartment of Molecular Genetics, The Ohio State University, Columbus, Ohio, USA.
Madeline R PriceDepartment of Molecular Genetics, The Ohio State University, Columbus, Ohio, USA.
Xiaokui M MoDepartment of Biomedical Informatics, Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Sue E KnoblaughDepartment of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA.
Takeshi KuritaThe Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Craig Joseph BurdDepartment of Molecular Genetics, The Ohio State University, Columbus, Ohio, USA.
The Ohio State University · USThe Ohio State University Wexner Medical Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
Defining the role of in utero estrogenic endocrine disruption on mammary gland stiffness and breast cancer riskR01ES032026 · NIEHS · OHIO STATE UNIVERSITY · PI BURD, CRAIG J · 2021 to 2025
$1.7M
NCI NIH HHS P30 CA016058NIEHS NIH HHS R01 ES032026
6 · The paper itself

Abstract

Development of the mammary gland requires both proper hormone signaling and cross talk between the stroma and epithelium. While estrogen receptor (ERα) expression in the epithelium is essential for normal gland development, the role of this receptor in the stroma is less clear. Moreover, several lines of evidence suggest that mouse phenotypes of in utero exposure to endocrine disruption act through mesenchymal ERα in the developing fetus. We utilized a Twist2-cre mouse line to knock out mesenchymal ERα. Herein, we assessed mammary gland development in the context of mesenchymal ERα deletion. We also tested the effect of in utero bisphenol A (BPA) exposure to alter the tumor susceptibility in the mouse mammary tumor virus-neu (MMTV-neu) breast cancer mouse model. Mesenchymal ERα deletion resulted in altered reproductive tract development and atypical cytology associated with estrous cycling. The mammary gland demonstrated mature epithelial extension unlike complete ERα-knockout mice, but ductal extension was delayed and reduced compared to ERα-competent mice. Using the MMTV-Neu cancer susceptibility model, ERα-intact mice exposed to BPA had reduced tumor-free survival and overall survival compared to BPA-exposed mice having mesenchymal ERα deletion. This difference is specific for BPA exposure as vehicle-treated animals had no difference in tumor development between mice expressing and not expressing mesenchymal ERα. These data demonstrate that mesenchymal ERα expression is not required for ductal extension, nor does it influence cancer risk in this mouse model but does influence the cancer incidence associated with in utero BPA exposure.

Indexed as

NeoplasmsReceptors, EstrogenAnimalsEpitheliumEstrogen Receptor alphaMammary Glands, AnimalMiceMice, KnockoutEstrogen Receptor alphaReceptors, Estrogenendocrine disruptorsestrogen receptormammary glandMMTV-Neu

Identifiers

PMID37855322
PMCPMC10698735
OpenAlexW4387579576

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.